![MYRIAD GENETICS INC [MYGN] reports annual net loss of $263,300,000.0](/_next/image?url=https%3A%2F%2F10kinfo-appdata.s3.us-west-2.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FMYGN.png&w=3840&q=75)
MYRIAD GENETICS INC [MYGN] reports annual net loss of $263,300,000.0
Company Reports Revenue of $753.2 million
MYRIAD GENETICS INC [MYGN] has reported a net loss of $263,300,000.0 for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $753.2 million
Based in SALT LAKE CITY, Utah, MYRIAD GENETICS INC operates in the MANUFACTURING sector.
The company's consolidated income statement for the 12 months ended December 31, 2023, showed a total revenue of $753.2 million, compared to $678.4 million in the previous year and $690.6 million in the year before that.
Costs and expenses for the period included research and development expenses of $88.7 million, selling, general, and administrative expenses of $572.9 million, legal settlements of $112.8 million, and goodwill and long-lived asset impairment charges of $0.0 million. The total costs and expenses amounted to $1,010.6 million, higher than the $819.0 million in the previous year and $881.1 million in the year before that.
